Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6

NCT03618758 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer Stage IV
Peritoneal Carcinomatosis
Intraperitoneal Paclitaxel
mFOLFOX6

Interventions

DRUG: Paclitaxel
DRUG: mFOLFOX6 regimen

Sponsor

Seoul National University Bundang Hospital

Collaborators

[object Object]
[object Object]